NCT05177887View on ClinicalTrials.gov

Traumacel PULVIS and Traumacel ENDO Applicator in the Post-market Surveillance Phase

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2023

Conditions
BleedingSurgical Wound
Interventions
DEVICE

Traumacel PULVIS, Traumacel ENDO Applicator

Haemostatic plant polysaccharide powder made of the oxidized cellulose with flexible applicator (38 cm).

Trial Locations (1)

50005

University Hospital Hradec Králové, Hradec Králové

All Listed Sponsors
lead

Bioster, a.s.

INDUSTRY